PubRank

F Capsoni

Author PubWeight™ 18.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibition of neutrophil oxidative metabolism by nimesulide. Agents Actions 1987 1.73
2 The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996 1.17
3 Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 2004 0.89
4 Defective suppressor cell activity in essential mixed cryoglobulinemia. J Clin Lab Immunol 1982 0.89
5 Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach. Br J Haematol 1991 0.87
6 Psoriasis during interferon beta treatment for multiple sclerosis. Neurol Sci 2009 0.87
7 Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis 2008 0.84
8 Effect of corticosteroids on neutrophil function: inhibition of antibody-dependent cell mediated cytotoxicity (ADCC). J Immunopharmacol 1983 0.83
9 Leucocyte function after antenatal betamethasone given to prevent respiratory distress. Lancet 1978 0.81
10 Polycythemia vera terminating in chronic neutrophilic leukemia: report of a case. Am J Hematol 1990 0.81
11 Letter: Phagocyte function in systemic lupus erythematosus. Lancet 1975 0.80
12 Neutrophil chemotactic factor of anaphylaxis (NCF-A) release in aspirin-induced asthma. Clin Allergy 1984 0.80
13 CD69 expression on neutrophils from patients with rheumatoid arthritis. Clin Exp Rheumatol 2004 0.79
14 Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity? Dermatology 1996 0.79
15 Cytotoxic mechanism in white blood cells. N Engl J Med 1979 0.79
16 Bone marrow and tissue expression of gpIIb/IIIa, LFA-1, Mac-1 and gp150,95 glycoproteins. Eur J Haematol 1989 0.78
17 Immunostimulation of neutrophil phagocytic function by RU41740 (Biostim) in elderly subjects. Allergol Immunopathol (Madr) 1992 0.78
18 Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies. Infection 1992 0.78
19 Successful treatment of resistant Behçet's disease with etanercept. Clin Exp Rheumatol 2005 0.77
20 Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. J Interferon Cytokine Res 1999 0.77
21 The diagnosis of early psoriatic arthritis. G Ital Dermatol Venereol 2013 0.76
22 Disseminated aspergillosis. Am J Dis Child 1982 0.76
23 Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis. Clin Exp Dermatol 2014 0.76
24 Immune function and renal transplantation in Fabry's disease. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985 0.76
25 Chronic granulomatous disease in a 23-year-old female. J Clin Lab Immunol 1986 0.75
26 [Demonstration of a granulocyte defect in aged persons correlated with the presence of autoantibodies]. Boll Ist Sieroter Milan 1976 0.75
27 Inhibition of polymorphonuclear leukocyte-mediated cytotoxicity by hydrocortisone "in vitro". Boll Ist Sieroter Milan 1981 0.75
28 Defective granulocyte chemotaxis and natural killer activity in a patient with recurrent infections. J Clin Lab Immunol 1986 0.75
29 Chronic granulomatous disease. Pediatr Radiol 1981 0.75
30 Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor. J Clin Lab Immunol 1986 0.75
31 Modulation of human polymorphonuclear leukocyte function by the flavonoid silybin. Int J Tissue React 1988 0.75
32 Thyroid acropachy: an unusual rheumatic manifestation of Graves' disease. Clin Exp Rheumatol 2005 0.75
33 Polymorphonuclear leukocyte function in burned patients: effect of isoprinosine. Panminerva Med 1984 0.75
34 Immunomodulating activity of RU 41740: in vitro and in vivo studies on human lymphocytes. Int J Immunopharmacol 1987 0.75
35 Successful cyclosporine treatment in a case of amicrobial pustulosis associated with immunological abnormalities. Int J Immunopathol Pharmacol 2009 0.75
36 [Effect of ambroxol on the activity of phagocytic cells in vitro]. Arch Monaldi 1985 0.75
37 [Deficits of granulocytic function in pathology of adult and pediatric ages. (Personal observations and review of the literature)]. Ric Clin Lab 1979 0.75
38 In vitro modulation of human monocytes functions by RU 41740 (Biostim). Int J Immunopharmacol 1988 0.75
39 Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis. Eur J Dermatol 1999 0.75
40 [Granulocyte function in patients in the acute phase of severe diseases]. Minerva Anestesiol 1981 0.75
41 IgG and C3 receptors on polymorphonuclear leukocytes in phagocytosis. Role of C3-receptors in the attachment and ingestion phases. Boll Ist Sieroter Milan 1977 0.75
42 A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS). Int J Tissue React 1986 0.75
43 Phagocytic function of polymorphonuclear leukocytes in essential mixed cryoglobulinaemia. Boll Ist Sieroter Milan 1982 0.75
44 Immunomodulation of polymorphonuclear leukocytes by D53 Immucytal and its constitutive fractions. Boll Ist Sieroter Milan 1989 0.75
45 The role of superoxide anion generation in antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity. Boll Ist Sieroter Milan 1979 0.75
46 Effect of ambroxol on human phagocytic cell function. Boll Ist Sieroter Milan 1985 0.75